Wockhardt Ltd
Sagar Satpute is a seasoned professional with extensive experience in business development, mergers and acquisitions, and corporate strategy within the pharmaceuticals industry. Since joining Wockhardt Ltd. in October 2012, Sagar has successfully led M&A activities, global out-licensing of novel antibiotics and biosimilars, and the divestment of key brand assets. Previous roles include Senior Manager at Bayer Pharmaceuticals, where responsibilities encompassed driving product-related business development and managing market research for global products, as well as positions at Dr. Reddy's Labs and Nicholas Piramal India Ltd. Sagar holds an MBA in Operations & Supply Chain from Welingkar Institute of Management and a B.Tech. in Electronics & Telecom from Doctor Babasaheb Ambedkar Technological University.
This person is not in any teams
This person is not in any offices
Wockhardt Ltd
1 followers
Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and Clavulanate Potassium for Oral Suspension, Azithromycin Tablets, Aciclovir Powder for Injection, Alendronic Acid, Amitriptyline, Clarithromycin, Entacapone Tablet and Flucloxacillin Injection. It operates a chain of approximately 10 super specialty hospitals, which offer treatment and care facilities in cardiology, neurosurgery, orthopedics, critical care, oncology, nephrology, urology and others. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. The Company has approximately three research centers globally.